Study designs for evaluating different efficacy and effectiveness aspects of vaccines
- PMID: 9384199
- DOI: 10.1093/oxfordjournals.aje.a009196
Study designs for evaluating different efficacy and effectiveness aspects of vaccines
Abstract
Vaccine efficacy and effectiveness (VE) are generally measured as 1 minus some measure of relative risk (RR) in the vaccinated group compared with the unvaccinated group (VE = 1 - RR). In designing a study to evaluate vaccination, the type of effect and the question of interest determine the appropriate choice of comparison population and parameter. Possible questions of interest include that of the biologic effect of vaccination on susceptibility, on infectiousness, or on progression to disease in individuals. The indirect effects, total effects, and overall public health benefits of widespread vaccination of individuals within the context of a vaccination program might also be of primary concern. The change in behavior induced by belief in the protective effects of vaccination might influence the estimates of these effects or might itself be of interest. In this paper, the authors present a framework of study designs that relates the scientific question of interest to the choice of comparison groups, the unit of observation, the level of information available for analysis, and the parameter of effect.
Similar articles
-
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.Stat Med. 1998 May 30;17(10):1121-36. doi: 10.1002/(sici)1097-0258(19980530)17:10<1121::aid-sim824>3.0.co;2-e. Stat Med. 1998. PMID: 9618773
-
On measures and models for the effectiveness of vaccines and vaccination programmes.Int J Epidemiol. 1988 Jun;17(2):456-63. doi: 10.1093/ije/17.2.456. Int J Epidemiol. 1988. PMID: 3403141
-
[From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Mar;58(3):263-73. doi: 10.1007/s00103-014-2109-y. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015. PMID: 25566841 German.
-
The challenge of vaccine safety.Semin Pediatr Infect Dis. 2002 Jul;13(3):215-20. doi: 10.1053/spid.2002.125865. Semin Pediatr Infect Dis. 2002. PMID: 12199618 Review.
-
Veterinary and human vaccine evaluation methods.Proc Biol Sci. 2014 Apr 16;281(1784):20132839. doi: 10.1098/rspb.2013.2839. Print 2014 Jun 7. Proc Biol Sci. 2014. PMID: 24741009 Free PMC article. Review.
Cited by
-
Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?Clin Infect Dis. 2021 Oct 5;73(7):1248-1256. doi: 10.1093/cid/ciab395. Clin Infect Dis. 2021. PMID: 33949666 Free PMC article.
-
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021-2022.Vaccines (Basel). 2024 Jan 7;12(1):58. doi: 10.3390/vaccines12010058. Vaccines (Basel). 2024. PMID: 38250871 Free PMC article.
-
Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions.Epidemiology. 2025 May 1;36(3):363-373. doi: 10.1097/EDE.0000000000001839. Epub 2025 Jan 24. Epidemiology. 2025. PMID: 39855261 Free PMC article.
-
Estimating Waning of Vaccine Effectiveness: A Simulation Study.Clin Infect Dis. 2023 Feb 8;76(3):479-486. doi: 10.1093/cid/ciac725. Clin Infect Dis. 2023. PMID: 36056892 Free PMC article.
-
Dissecting the indirect effects caused by vaccines into the basic elements.Hum Vaccin Immunother. 2015;11(9):2142-57. doi: 10.1080/21645515.2015.1052196. Epub 2015 Jul 17. Hum Vaccin Immunother. 2015. PMID: 26186100 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical